ACADIA Pharmaceuticals Inc (ACAD)
15.28
+0.18
(+1.16%)
USD |
NASDAQ |
May 21, 16:00
15.28
0.00 (0.00%)
After-Hours: 18:07
ACADIA Pharmaceuticals Cash from Investing (TTM): -174.56M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -174.56M |
| December 31, 2023 | 32.00M |
| September 30, 2023 | 14.60M |
| June 30, 2023 | -4.072M |
| March 31, 2023 | 134.41M |
| December 31, 2022 | 73.24M |
| September 30, 2022 | 162.54M |
| June 30, 2022 | -9.224M |
| March 31, 2022 | 29.37M |
| December 31, 2021 | -71.10M |
| September 30, 2021 | -259.61M |
| June 30, 2021 | 49.71M |
| March 31, 2021 | 193.78M |
| December 31, 2020 | 192.51M |
| September 30, 2020 | 100.32M |
| June 30, 2020 | -42.75M |
| March 31, 2020 | -158.99M |
| December 31, 2019 | -165.84M |
| September 30, 2019 | -145.64M |
| June 30, 2019 | -123.78M |
| March 31, 2019 | -138.35M |
| December 31, 2018 | -71.49M |
| September 30, 2018 | 99.37M |
| June 30, 2018 | 86.92M |
| March 31, 2018 | 129.16M |
| Date | Value |
|---|---|
| December 31, 2017 | 92.47M |
| September 30, 2017 | 179.71M |
| June 30, 2017 | 5.466M |
| March 31, 2017 | -40.29M |
| December 31, 2016 | -261.92M |
| September 30, 2016 | -274.34M |
| June 30, 2016 | -111.12M |
| March 31, 2016 | -59.60M |
| December 31, 2015 | 147.57M |
| September 30, 2015 | 131.32M |
| June 30, 2015 | 161.89M |
| March 31, 2015 | 50.31M |
| December 31, 2014 | -87.27M |
| September 30, 2014 | -118.21M |
| June 30, 2014 | -161.02M |
| March 31, 2014 | -192.13M |
| December 31, 2013 | -126.10M |
| September 30, 2013 | -170.70M |
| June 30, 2013 | -169.50M |
| March 31, 2013 | -62.49M |
| December 31, 2012 | -25.53M |
| September 30, 2012 | 13.34M |
| June 30, 2012 | 20.56M |
| March 31, 2012 | 18.59M |
| December 31, 2011 | 5.98M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-259.61M
Minimum
Sep 2021
193.78M
Maximum
Mar 2021
-8.654M
Average
5.262M
Median
Cash from Investing (TTM) Benchmarks
| Regulus Therapeutics Inc | -79.05M |
| Amylyx Pharmaceuticals Inc | 36.88M |
| Alnylam Pharmaceuticals Inc | -327.75M |
| Cassava Sciences Inc | -0.057M |
| Oragenics Inc | -- |